HIV in Europe 2018: Epidemiology, Patient Flow, Prevalence and Diagnosed & Treated Patient Analysis (2017-2026) - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 5, 2018--The “Europe HIV Epidemiology and Patient Flow Analysis - 2018” report has been added to ResearchAndMarkets.com’s offering.
The research provides insights into HIV epidemiology, HIV diagnosed patients, and HIV treatment rate for EU5 countries. The research measures key indicators including prevalence of HIV derived from epidemiological analysis, patients diagnosed with HIV, and patients treated with a drug therapy.
The research study helps executives estimate HIV market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The research provides estimates and forecasts of HIV prevalence, HIV diagnosis rate, and HIV treatment rate for the period 2017-2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.
Key Topics Covered
1. HIV Disease Definition
2. HIV Patient Flow in Europe
3. HIV Patient Flow in Germany
4. HIV Patient Flow in France
5. HIV Patient Flow in Spain
6. HIV Patient Flow in Italy
7. HIV Patient Flow in UK
8. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/research/3g3cgj/hiv_in_europe?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180705005484/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:HIV/AIDS Drugs
INDUSTRY KEYWORD: HEALTH AIDS INFECTIOUS DISEASES PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/05/2018 01:32 PM/DISC: 07/05/2018 01:31 PM